Zobrazeno 1 - 10
of 426
pro vyhledávání: '"Martin, Haluzik"'
Autor:
Barbora Judita Kasperova, Milos Mraz, Petr Svoboda, Daniel Hlavacek, Helena Kratochvilova, Istvan Modos, Nikola Vrzackova, Peter Ivak, Petra Janovska, Tatyana Kobets, Jakub Mahrik, Martin Riecan, Lenka Steiner Mrazova, Viktor Stranecky, Ivan Netuka, Tomas Cajka, Ondrej Kuda, Vojtech Melenovsky, Sona Stemberkova Hubackova, Martin Haluzik
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract Background Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are glucose-lowering agents used for the treatment of type 2 diabetes mellitus, which also improve heart failure and decrease the risk of cardiovascular complications. Epicardial
Externí odkaz:
https://doaj.org/article/f5b7b9bcaae44ad086f3948fb34547db
Autor:
Ondrej Krystynik, David Karasek, Michal Kahle, Veronika Kubickova, Dominika Macakova, Lubica Cibickova, Milos Mraz, Martin Haluzik
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-9 (2023)
Abstract Backgrounds Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) may be involved in pathogenesis of gestational diabetes mellitus (GDM). The aim was to compare GLP-1 and GIP production in fasting state and durin
Externí odkaz:
https://doaj.org/article/f25f29ed26fd4f04addc9ba15eafa8d0
Autor:
Eliska Vacurova, Jaroslava Trnovska, Petr Svoboda, Vojtech Skop, Vendula Novosadova, David Pajuelo Reguera, Silvia Petrezselyová, Benoit Piavaux, Berwini Endaya, Frantisek Spoutil, Dagmar Zudova, Jan Stursa, Magdalena Melcova, Zuzana Bielcikova, Lukas Werner, Jan Prochazka, Radislav Sedlacek, Martina Huttl, Sona Stemberkova Hubackova, Martin Haluzik, Jiri Neuzil
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Senescent cells play a role in pathogenesis of diabetes, and senolytic agents can improve obesity- and diabetes-related pathologies. Here the authors report that mitochondrially targeted tamoxifen, a potential anti-cancer agent with senolytic activit
Externí odkaz:
https://doaj.org/article/e1a97d3a7b444e588a78bce984149ca2
Autor:
Marketa Vavreckova, Natalie Galanova, Martin Kostovcik, Ondrej Krystynik, Eliska Ivanovova, Radka Roubalova, Zuzana Jiraskova Zakostelska, David Friedecky, Jaroslava Friedecka, Martin Haluzik, David Karasek, Klara Kostovcikova
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
AimsGestation is linked to changes in gut microbiota composition and function. Since gestational diabetes mellitus (GDM) can develop at any time of the pregnancy, we stratified the women into four groups according to the time and test used for the di
Externí odkaz:
https://doaj.org/article/adc5463b38c4489cb66a7bb10546729b
Autor:
Irena Markova, Martina Hüttl, Olena Oliyarnyk, Tereza Kacerova, Martin Haluzik, Petr Kacer, Ondrej Seda, Hana Malinska
Publikováno v:
Nutrition & Metabolism, Vol 16, Iss 1, Pp 1-10 (2019)
Abstract Background and aims Dicarbonyl stress plays an important role in the pathogenesis of microvascular complications that precede the formation of advanced glycation end products, and contributes to the development of renal dysfunction. In renal
Externí odkaz:
https://doaj.org/article/4017ad84a2e04c1a9e915442955886fe
Autor:
Andrej Janez, Emir Muzurovic, Anca Pantea Stoian, Martin Haluzik, Cristian Guja, Leszek Czupryniak, Lea Duvnjak, Nebojsa Lalic, Tsvetalina Tankova, Pawel Bogdanski, Nikolaos Papanas, Josè Silva Nunes, Peter Kempler, Zlatko Fras, Manfredi Rizzo
Publikováno v:
International Journal of Cardiology. 365:8-18
Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of the endogenous GLP-1 incretin hormone, improving glycaemic control in type 2 diabetes mellitus (T2DM) by increasing insulin secretion and decreasing glucagon secretion in a glucose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2313f85e6867e4c8c63884604c485be3
https://doi.org/10.1016/j.ijcard.2022.07.017
https://doi.org/10.1016/j.ijcard.2022.07.017
Autor:
Robert E.J. Ryder, Katharina Laubner, Marek Benes, Martin Haluzik, Lynne Munro, Harry Frydenberg, Julian P. Teare, Aruchuna Ruban, Sigal Fishman, Erwin Santo, Rainer Stengel, Charlotte De Jonge, Jan W. Greve, Ricardo V. Cohen, Cristina M. Aboud, Gerald J. Holtmann, Graeme Rich, Jess J. McMaster, Tadej Battelino, Primoz Kotnik, James P. Byrne, John C. Mason, Justin Bessell, Jeanine Bascomb, Lillian Kow, Janes Collins, Jacob Chisholm, Peter N. Pferschy, Harald Sourij, Melissa L. Cull, Melanie C. Wyres, Russell Drummond, Barbara McGowan, Stephanie A. Amiel, Mahi Yadagiri, Piya Sen Gupta, Jens Aberle, Jochen Seufert
Publikováno v:
Diabetes Care. 46:e89-e91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dab10af8e13494185d21848d0f3e18f3
https://doi.org/10.2337/dc22-1952
https://doi.org/10.2337/dc22-1952
Autor:
David Cuesta-Frau, Daniel Novák, Vacláv Burda, Daniel Abasolo, Tricia Adjei, Manuel Varela, Borja Vargas, Milos Mraz, Petra Kavalkova, Marek Benes, Martin Haluzik
Publikováno v:
Complexity, Vol 2019 (2019)
Diabetes is a disease of great and rising prevalence, with the obesity epidemic being a significant contributing risk factor. Duodenal–jejunal bypass liner (DJBL) is a reversible implant that mimics the effects of more aggressive surgical procedure
Externí odkaz:
https://doaj.org/article/0d4e1b13c31d4eb697b075f1fedde8bf
Autor:
Martin Haluzik, Markéta Kubíčková, Jan Škrha, Filip Málek, Miloš Táborský, Jiří Veselý, Martin Prázný, Aleš Linhart
Publikováno v:
Vnitřní lékařství. 67:404-410
Diabetes mellitus je významným rizikovým faktorem rozvoje srdecniho selhani a přitomnost diabetu zaroveň zhorsuje prognozu nemocných se srdecnim selhanim. Jednou z významných novinek v lecbě srdecniho selhani jsou glifloziny, ktere blokadou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd835a8c58d78e7911fad57fcfb8d79b
https://doi.org/10.36290/vnl.2021.108
https://doi.org/10.36290/vnl.2021.108
Autor:
Martin Haluzik, Peter Novodvorský
Publikováno v:
Expert Opinion on Drug Safety. 21:349-361
Introduction Recent development of novel antidiabetic drugs with proven cardiovascular (CV) and renal benefit and positive effect on body weight enable to take a more complex approach toward the management of type 2 diabetes mellitus (T2DM). Fixed-ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da876926bcd9998385782cd25d48c48a
https://doi.org/10.1080/14740338.2021.1978974
https://doi.org/10.1080/14740338.2021.1978974